E. Tortoli, Microbiological features and clinical relevance of new species of the genus 222

P. Brennan and H. Nikaido, The Envelope of Mycobacteria, Annual Review of Biochemistry, vol.64, issue.1, pp.29-224, 1995.
DOI : 10.1146/annurev.bi.64.070195.000333

K. Dheda, T. Gumbo, G. Maartens, K. Dooley, R. Mcnerney et al., The epidemiology, pathogenesis, transmission, diagnosis, and management of multidrug-resistant, extensively drug-resistant, and incurable tuberculosis, The Lancet Respiratory Medicine, vol.5, issue.4, pp.291-360, 2017.
DOI : 10.1016/S2213-2600(17)30079-6

D. Griffith and T. Aksamit, Understanding nontuberculous mycobacterial lung disease: it???s been a long time coming, F1000Research, vol.5, pp.2797-230, 2016.
DOI : 10.12688/f1000research.9272.1

URL : https://doi.org/10.12688/f1000research.9272.1

B. Seaworth and D. Griffith, Therapy of Multidrug-Resistant and Extensively Drug-Resistant 231

G. Johnson, The alpha/beta Hydrolase Fold Proteins of Mycobacterium tuberculosis, p.236

V. Point, R. Malla, S. Diomande, B. Martin, V. Delorme et al., Synthesis and Kinetic Evaluation of Cyclophostin and Cyclipostins Phosphonate Analogs As Selective and Potent Inhibitors of Microbial Lipases, Journal of Medicinal Chemistry, vol.55, issue.22, pp.10204-10223, 2012.
DOI : 10.1021/jm301216x

B. Martin, E. Vasilieva, C. Dupureur, C. Spilling, E. Vasilieva et al., Synthesis and comparison of the 241 biological activity of monocyclic phosphonate, difluorophosphonate and phosphate analogs of 242 the natural AChE inhibitor cyclophostin, Bioorg Med Chem, vol.2310, issue.243, pp.7529-7563, 2015.

E. Herrán, Antimicrobial Susceptibility Testing for Mycobacterium sp, p.255

J. Palomino, A. Martin, M. Camacho, H. Guerra, J. Swings et al., Resazurin Microtiter Assay Plate: Simple and Inexpensive Method for Detection of Drug Resistance in Mycobacterium tuberculosis, Antimicrobial Agents and Chemotherapy, vol.46, issue.8, pp.2720-2722, 2002.
DOI : 10.1128/AAC.46.8.2720-2722.2002

J. Rybniker, A. Vocat, C. Sala, P. Busso, F. Pojer et al., Lansoprazole is an 261 antituberculous prodrug targeting cytochrome bc1, Nat Commun, vol.616, issue.262, p.7659, 2015.
DOI : 10.1038/ncomms8659

URL : http://www.nature.com/articles/ncomms8659.pdf

M. Mycobacteria, bovis BCG Pasteur Reference strain M. tuberculosis mc 2 6230 Reference strain